2-Cyclopenten-1-one,2-(1-hydroxy-1-methylethyl)- 5-[(3â,5R,17â)-3-hydroxy-4,4,8,14- tetramethyl-18-norandrostan-17-yl]-,(R)- (134441-00-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 18-Norandrostan-17-one,3-hydroxy-,(3â,- 5R)-
- Benzo[3,4]-18-norandrosta-3,12,15-trien-17- one,6'-ethyl-1',2',3',4',5',6'-hexahydro-7- hydroxy-4,6',8-trimethyl-,(3â,4R,6'R,7â,8R,9â,- 10R,14â)-
- â-D-Glucopyranoside,(1S,2R,3R,4R)-2-[(3â,4â,- 5R,17â)-3-[(O-6-deoxy-R-Lmannopyranosyl-( 1f2)-O-[6-deoxy-R-Lmannopyranosyl-( 1f6)]-â-D-glucopyranosyl)- oxy]-4-(hydroxymethyl)-4,14-dimethyl-9,19- cycloandrostan-17-yl]-3-hydroxy-4-(1- hydroxy-1-methylethyl)cyclopentyl O-â-D-glucopyranosyl-(1f2)-O-[â-Dxylopyranosyl-( 1f6)]-
- Cyclopenta[13,17]-18-norandrosta-6,8(14)- dien-11-one,3',4',5',17-tetrahydro-3,5,9- trihydroxy-4'-[(1S,2R)-1-hydroxy-2,3- dimethylbutyl]-3'-methyl-,(3â,3'â,4'â,5â,9â,- 17R)-
- Estr-4-en-3-one,17-hydroxy-16-(1-methylethyl)-,(16â,17â)-
- Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide
- 18-Norandrostane-4-propanoic acid,13-carboxy-â,6-dihydroxy-4,9- dimethyl-3,15-bis(1-methylethenyl)-,Elactone,(âR,3R,4â,5â,6â,8R,9â,10R,13R,14â,15â,- 17â)-
- 2(1H)-Pyridinone,5-[(3â,5â,14â,17â)-3,14- dihydroxyandrostan-17-yl]-
- Estra-4,9-dien-3-one,11-(4-fluorophenyl)- 17-hydroxy-17-(1-propynyl)-,(11â,17â)-
- Estra-4,9-dien-3-one,17-hydroxy-11-(4- methoxyphenyl)-17-(1-propynyl)-,(11â,17â)-
- Estra-4,9-dien-3-one,11-[4-(dimethylamino)- phenyl]-17-hydroxy-17-(1-propynyl)-,(11â,- 13R,17â)-
- Estra-4,9-dien-3-one,17-hydroxy-17-(1- propynyl)-11-(2-thienyl)-,(11â,17â)-
- Estra-4,9-dien-3-one,17-hydroxy-11- phenyl-17-(1-propynyl)-,(11â,17â)-
- Estra-4,9-dien-3-one,11-ethenyl-17- hydroxy-17-(1-propynyl)-,(11â,17â)-
- Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(1-methylethyl)-,(2'â,5'R)-
- Benz[3,4]-18-norandrost-3-ene,hexahydro-3,- 3',4',9,14-pentamethyl-13-(1-methylethyl)-,(3â,3'â,4â,4'R,5â,8R,9â,10R,14â)-
- Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
- Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
- 3-beta-hydroxy-norandrostan-4-en-17-one
- 3-beta-hydroxy-norandrostan-4-en-17-one